发明授权
US08367641B2 Use of modified oligo-β-(1,3)-glucans for treating diseases of the immune system, oligo-β-(1,3)-glucan-(1,3)-mannose, oligo-β-(1,3)-glucan-(1,3)-mannitol and derivatives thereof, methods for preparing them and medicaments containing them
失效
使用修饰的寡聚 - （1,3）葡聚糖来治疗免疫系统的疾病，寡糖 - （1,3） - 葡聚糖 - （1,3） - 甘露糖，寡聚体 1,3） - 葡聚糖 - （1,3） - 甘露醇及其衍生物，其制备方法和含有它们的药物
- 专利标题： Use of modified oligo-β-(1,3)-glucans for treating diseases of the immune system, oligo-β-(1,3)-glucan-(1,3)-mannose, oligo-β-(1,3)-glucan-(1,3)-mannitol and derivatives thereof, methods for preparing them and medicaments containing them
- 专利标题（中）： 使用修饰的寡聚 - （1,3）葡聚糖来治疗免疫系统的疾病，寡糖 - （1,3） - 葡聚糖 - （1,3） - 甘露糖，寡聚体 1,3） - 葡聚糖 - （1,3） - 甘露醇及其衍生物，其制备方法和含有它们的药物
-
申请号： US12520612申请日： 2007-12-20
-
公开(公告)号： US08367641B2公开(公告)日： 2013-02-05
- 发明人: Jean-Claude Yvin , Karine Descroix , Vincent Ferrieres , Frank Jamois , Isabelle Laurent , Vaclav Vetvika
- 申请人： Jean-Claude Yvin , Karine Descroix , Vincent Ferrieres , Frank Jamois , Isabelle Laurent , Vaclav Vetvika
- 申请人地址： FR Paris
- 专利权人： ASE & BIO
- 当前专利权人： ASE & BIO
- 当前专利权人地址： FR Paris
- 代理机构： Stites & Harbison PLLC
- 代理商 B. Aaron Schulman, Esq.
- 优先权： FR0611333 20061222
- 国际申请： PCT/FR2007/052595 WO 20071220
- 国际公布： WO2008/087340 WO 20080724
- 主分类号： A61K31/702
- IPC分类号： A61K31/702 ; A61K31/716 ; C07H3/06
摘要：
The present invention relates to the use of at least one compound of formula (I) or (II), in which R1 is H and n is an integer from 2 to 10, for the preparation of a medicament for treating diseases chosen from the group comprising tumour, cancer, viral disease, bacterial disease, fungal disease, disease of the immune system, auto-immune disease or disease linked to a deficiency in immunostimulation, in human beings and warm-blooded animals. The invention also relates to new products having a mannose or mannitol termination as well as a method for preparing them.
信息查询
